Synergistic Activity of Carfilzomib and Panobinostat in Multiple Myeloma Cells via Modulation of ROS Generation and ERK1/2

Relapse of disease and subsequent resistance to established therapies remain as major challenges in the treatment of multiple myeloma (MM). New therapeutic options are needed for these extensively pretreated patients. To explore an optimized combinational therapy, interactions between the irreversib...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Lu, Gao, Minjie, Yang, Guang, Tao, Yi, Kong, Yuanyuan, Yang, Ruixue, Meng, Xiuqin, Ai, Gongwen, Wei, Rong, Wu, Huiqun, Wu, Xiaosong, Shi, Jumei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4427084/
https://www.ncbi.nlm.nih.gov/pubmed/26000292
http://dx.doi.org/10.1155/2015/459052

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4427084/
https://www.ncbi.nlm.nih.gov/pubmed/26000292
http://dx.doi.org/10.1155/2015/459052

Ejemplares similares